Giriş: Karaciğer sirozu hastalarında sitopeniler klinik bir problem olarak hasta takiplerinde ortaya çıkabilmektedir. Biz bu çalışmada trombosit sayısı 100 bin/mikrolitre’nin altında olan karaciğer sirozu hastalarında, dalak boyutları ile trombosit/WBC/nötrofil/lenfosit/monosit düzeyleri arasında bir ilişki olup olmadığını değerlendirmeyi amaçladık. Materyal ve Metod: Hastalar, dalak boyutlarına göre 4 gruba ayrıldı. Dalak boyutu normal olarak bildirilmiş olan hastalar (Dalak uzunluğu ≤ 13 cm(santimetre) olan hastalar da bu gruba dahil edildi) birinci grup , dalak uzunluğu 13 cm-15 cm arasında olanlar ( 13 cm dahil değil, 15 cm dahil değil) ikinci grup , dalak uzunluğu 15 cm – 18 cm arasında olanlar (15 cm dahil, 18 cm dahil değil) üçüncü grup, dalak uzunluğu ≥18 cm olanlar dördüncü grup olarak sınıflandırıldı. Gruplar arasında WBC, nötrofil, lenfosit, monosit düzeylerine göre farklılık olup olmadığı araştırıldı. Bulgular: Dalak uzunluğu ≥18 cm olanlarda dalak uzunluğu < 15 cm olanlara göre trombosit düzeyinin istatistiksel olarak anlamlı düzeyde daha düşük olduğu görüldü (p
Background and Objectives: Obesity is a major global public health problem associated with numerous complications. Likewise, the use of antiplatelet and anticoagulant agents has increased with population aging and the growing burden of cardiovascular diseases. This study aimed to evaluate the effects of obesity and antiplatelet/anticoagulant therapy on the clinical presentation, bleeding severity, and short-term clinical outcomes of patients with gastrointestinal bleeding. Materials and Methods: A prospective cohort study was conducted in consecutive patients admitted with upper or lower gastrointestinal bleeding to a tertiary referral center between January 2024 and January 2025. Patients were categorized according to body mass index (BMI) and antithrombotic therapy status. Clinical characteristics, bleeding severity scores, treatment requirements, and short-term clinical outcomes were compared. Multivariable multinomial logistic regression analysis was performed to identify independent associations. Results: A total of 177 patients were included. Obese and overweight patients were significantly older than normal-weight patients (p = 0.001), whereas no significant differences were observed among BMI groups regarding the Glasgow–Blatchford score, pre-endoscopic Rockall score, transfusion requirements, endoscopic intervention, or short-term clinical outcomes. Patients receiving antiplatelet or anticoagulant therapy had significantly higher Charlson Comorbidity Index, bleeding severity scores, and packed red blood cell transfusion requirements than those receiving no antithrombotic therapy (all p < 0.01). However, after multivariable adjustment, these associations did not remain independent, and advanced age remained the only independent factor common to both treatment groups. Conclusions: Obesity was not independently associated with bleeding severity or short-term clinical outcomes in patients with gastrointestinal bleeding. Although antiplatelet and anticoagulant therapy were associated with more severe bleeding-related clinical findings, these associations were not independent after multivariable adjustment.
This study investigated the potential association between gastric intestinal metaplasia, Helicobacter pylori (H pylori) positivity and ABO/Rh blood types. Additionally, the study examined the association between intestinal metaplasia and H pylori positivity. The study population consisted of 297 patients aged 19 years and older who underwent endoscopic biopsies for the assessment of intestinal metaplasia and H pylori infection. Patients’ ABO/Rh blood type information was retrieved from the hospitals electronic archive system. Comparative analyses were performed to assess the distribution of ABO/Rh blood types among patients with and without intestinal metaplasia and H pylori infection. No statistically significant correlation was observed between H pylori positivity on endoscopic biopsy and ABO/Rh blood types. Similarly, there was no statistically significant correlation between intestinal metaplasia and ABO/Rh blood types. However, a significant association was identified between H pylori infection and intestinal metaplasia. The observed association between H pylori infection and intestinal metaplasia underscores the importance of H pylori testing in patients diagnosed with intestinal metaplasia. While our findings suggest that ABO/Rh blood type may not be a risk factor for intestinal metaplasia or H pylori infection, further research with a larger sample size is warranted to confirm these results, particularly in light of existing conflicting data in the literature.
20 September 2026 in International Journal for Vitamin and Nutrition Research
Background: Diabetic nephropathy (DN) is a major cause of chronic kidney disease and remains a substantial contributor to morbidity worldwide. This study aimed to assess seasonal variation in serum 25-hydroxyvitamin D (25(OH)D) concentrations among patients attending the clinic and to examine associations between these concentrations and albuminuria, as well as other metabolic and biochemical parameters, in patients with DN. Methods: This retrospective cross-sectional study included 298 patients with DN admitted to a tertiary university hospital between 2017 and 2023. Patients were divided into four groups based on the season in which their blood samples were collected. Serum 25(OH)D levels, albuminuria, lipid profiles, and glycemic markers were measured. Differences in clinical parameters across seasons among clinic attendees and their associations with serum 25(OH)D levels were assessed using group comparisons, correlation analysis, and multiple linear regression. Results: The mean serum 25(OH)D concentration was 16.1 ± 8.2 ng/mL and varied significantly across seasons (p < 0.001). Vitamin D concentrations were lowest in winter and spring and highest in summer and autumn. Albuminuria levels differed significantly across the four seasonal groups (p = 0.016); however, none of the pairwise comparisons remained significant after Bonferroni correction. In multivariable regression analysis, albuminuria was independently and inversely associated with serum Vitamin D levels (p < 0.001). Conclusions: Serum 25(OH)D concentrations varied by the season of sample collection, and lower concentrations were cross-sectionally associated with higher urine albumin-to-creatinine ratio (UACR). Prospective longitudinal and interventional studies are needed to establish temporality and determine whether Vitamin D supplementation affects renal outcomes.
30 July 2025 in Journal of Health Sciences and Medicine
Aims: This study investigated the clinical profiles of patients diagnosed with portal vein thrombosis (PVT) in Isparta, Turkiye. Methods: This study enrolled 68 PVT patients who presented to Süleyman Demirel University Faculty of Medicine between January 4, 2021, and December 31, 2024 (inclusive of both dates). Eligible participants were adults over 18 years of age with a confirmed diagnosis of PVT identified via ultrasonography, documented within patient records during the specified period, with the initial diagnosis occurring within the specified study period. Results: Among the 68 patients diagnosed with portal vein thrombosis, tumor thrombus was identified in 4 patients (5.9%). Portal region primary malignancies were identified in 11 of 68 PVT cases (16.2%), including stomach cancer (n=3), hepatocellular carcinoma (n=4), cholangiocarcinoma (n=2), and pancreatic cancer (n=2). Of the 64 patients without tumor thrombus, 31 (48.4%) had comorbid liver cirrhosis, while 33 (51.6%) did not. Additionally, our study found that approximately 12.5% of patients without tumor thrombus had atrial fibrillation. The study also identified essential thrombocytosis or polycythemia vera in approximately 7.8% (5 patients) of PVT cases without tumor thrombus. Conclusion: The findings emphasize the need for vigilance regarding the potential development of PVT during the follow-up of patients with liver cirrhosis. Malignancies arising in the portal venous drainage territory or adjacent organs represent notable risk factors for PVT development. In addition, in cases of unexplained portal vein thrombosis, particularly when accompanied by findings such as thrombocytosis or polycythemia, myeloproliferative neoplasms should also be included in the differential diagnosis.